• No results found

Hepatic steatosis : metabolic consequences Boer, A.M. den

N/A
N/A
Protected

Academic year: 2021

Share "Hepatic steatosis : metabolic consequences Boer, A.M. den"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Hepatic steatosis : metabolic consequences

Boer, A.M. den

Citation

Boer, A. M. den. (2006, November 21). Hepatic steatosis : metabolic consequences. GildePrint B.V., Enschede. Retrieved from https://hdl.handle.net/1887/4984

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4984

(2)
(3)

List of Publications

1. Annalise M. Martin, Emma Hammond, David Nolan, Craig Pace, Marion den Boer, Louise Taylor, Henry Moore, Olivia P. Martinez, Frank T Christiansen, Simon Mallal. Accumulation of Mitochondrial DNA Mutations in Human Immunodeficiency Virus-infected Patients Treated with Nucleoside-analogue Reverse-transcriptase Inhibitors. Am J Hum Genet 2003 Mar; 72(3):549-60

2. Marion den Boer, Peter J. Voshol, Folkert Kuipers, Louis M. Havekes, Johannes A. Romijn. Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models. Arterioscler Thromb Vasc Biol 2004; 24: 644-649

3. Blandine Franke-Fayard, Chris J. Janse, Margarida Cunha-Rodrigues, Jal Ramesar, Philippe Buscher, Ivo Que, Clemens Lowik, Peter J. Voshol, Marion A.M. den Boer, Sjoerd G. van Duinen, Maria Febbraio, Maria M. Mota and Andrew P. Waters. Murine Malaria Parasite Sequestration: CD36 is the Major Receptor, but Cerebral Pathology is Unlinked to Sequestration. Proc Nat Acad Sciences 2005 Aug 9;102(32):11468-73

4. Marion A.M. den Boer, Jeltje R. Goudriaan, Patrick C.N. Rensen, Maria Febbraio, Folkert Kuipers, Johannes A. Romijn, Louis M. Havekes, and Peter J. Voshol. CD36 Deficiency in Mice Impairs Lipoprotein Lipase-Mediated Triglyceride Clearance.

Journal of Lipid Res 2005 Oct;46(10):2175-81

5. Marion A.M. den Boer, Jimmy F.P. Berbée, Peter Reiss, Marc van der Valk, Peter J. Voshol, Folkert Kuipers, Louis M. Havekes, Patrick C.N. Rensen, Johannes A. Romijn. Ritonavir Impairs LPL-mediated Lipolysis And Decreases Uptake of Fatty Acids in Adipose Tissue. Arterioscler Thromb Vasc Biol 2006 Jan;26(1):124-9

6. Marion A.M. den Boer, Peter J. Voshol, Janny P. Schröder-van der Elst, Elena Korsheninnikova, D. Margriet Ouwens, Folkert Kuipers, Louis M. Havekes, Johannes A. Romijn. Endogenous IL-10 Protects Against Hepatic Steatosis, but Does Not Improve Insulin Sensitivity During High Fat Feeding in Mice. Endocrinology May 2006 in press

(4)

7. Marion A.M. den Boer, Peter J. Voshol, Folkert Kuipers, Johannes A. Romijn, Louis M. Havekes. Hepatic Glucose Production is More Sensitive to Insulin-mediated Inhibition than Hepatic VLDL-triglyceride Production. Am J Physiol Endocrinol

Metab 2006 in press

8. Marion A.M. den Boer, Marit Westerterp, Lihui Hu, Sonia M.S. Espirito Santo, A. Jitske van der Weij, Peter Reiss, Patrick C.N. Rensen, Johannes A. Romijn, Louis M. Havekes. Ritonavir Protects Against the Development of Atherosclerosis Despite an Atherogenic Lipoprotein Profile in APOE*3-Leiden Transgenic Mice (in preparation)

(5)

List of Publications

Referenties

GERELATEERDE DOCUMENTEN

In FA metabolism the liver also plays an important role: it is involved in FA uptake from plasma, FA oxidation, de novo FA synthesis, and VLDL- TG secretion.. Moreover, FA and

CD36 mice lacking the FA transporter that is normally present in muscle and adipose tissue, showed increased hepatic TG content and a decreased sensitivity of hepatic

By using this animal model we were able to measure the effect of insulin on HGO and hepatic VLDL-TG production, and in the same time also on peripheral glucose uptake and plasma

10 that the VLDL-TG production rate may be enhanced in CD36-deficient mice, but the increased plasma TG levels may also be due to increased intestinal lipid absorption or a

Our data indicate that, in contrast to our expectations, basal IL-10 production protects against hepatic steatosis during high fat feeding, but does not improve hepatic or

Plasma TG, cholesterol and free FA were measured in APOE*3-Leiden transgenic mice after a five-week run-in period on the western type diet (t=0) and, subsequently, again after 2

In contrast to our expectations, we observed that RTV significantly decreased atherosclerotic lesion area and severity in APOE*3-Leiden mice, compared to control mice, independent of

We showed in Chapter 4 that the increased plasma TG levels in CD36 deficiency were not due to a previously hypothesized enhancing effect on hepatic VLDL-TG production or an effect on